Synapse - Find an Expert

5913 Results

Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma

Meeting Abstract

Johnson, M. L.; Sima, C.; Paik, P. K.; Janjigian, Y. Y.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Use of integrated genomic analysis to evaluate BRCA-associated protein 1 (BAP1) as a mutated gene in malignant pleural mesothelioma (MPM)

Meeting Abstract

Bott, M. J.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Zhou, Q.; Olshen, A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Effect of EGFR and IGF1R on feedback activation of AKT arising from inhibition of mTOR in malignant pleural mesothelioma (MPM)

Meeting Abstract

Brevet, M.; Shimizu, S.; Zhou, Q.; Olshen, A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Antitumor activity of SNX-2112, a synthetic heat shock protein 90 inhibitor, in malignancies with amplification of the MET oncogene

Meeting Abstract

Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C.; Zeng, Z.; Viale, A.; Olshen, A.; Christensen, J. G.; Rosen, N.; Solit, D. B.; Weiser, M. R.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Circulating tumor cells (CTC) and prostate specific antigen (PSA) as response indicator biomarkers in chemotherapy-naive patients with progressive castration-resistant prostate cancer (CRPC) treated with MDV3100

Meeting Abstract

Anand, A.; Scher, H. I.; Beer, T. M.; Higano, C. E.; Danila, D. C.; Taplin, M.; Efstathiou, E.; Hirmand, M.; Sawyers, C. L.; Heller, G.; more...
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

PI3K mutations are more common in low grade DCIS

Meeting Abstract

Sakr, R.; Chandarlapaty, S.; Andrade, V.; Giri, D.; Muhsen, S.; Paik, W.; Morrow, M.; Rosen, N.; King, T.
Cancer Research (2010)

Fulltext@MSK | Save

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

Meeting Abstract

Abdel-Wahab, O.; Pardanani, A.; Patel, J.; Lasho, T.; Heguy, A.; Levine, R.; Tefferi, A.
Blood (2010)

Fulltext@MSK | Save

GVHD, hematopoietic, dysfunction, and post-transplant immune, deficiency: Loss of marrow function, leads to ineffective extramedullary hematopoiesis, however lymphoid reconstitution is restored by the synergistic effects of KGF, sex steroid ablation, and precursor T Cell adoptive therapy